Hemoglobin HbA1c Biosensor:

The need

HbA1c considered as the most famous biomarker for long term monitoring glycemic status of diabetic people. The prevalence of diabetes is increasing worldwide; hence, it was near 2.8% in 2000 with expectation to reach 4.4% at the end of 2030 costing from 171 million to 350 million in 2030 respectively.

Methods currently used

Most of methods used for measuring HbA1c are time consuming, restricted to specific places to be done, require pre-sample preparations, time consuming, need large sample volume, need highly skilled stuff members and most importantly highly expensive.

Our solution:

The urgent need for more cost-effective, sensitive and user friendly methods and regimens, leading to the appearance of HbA1c biosensors which in turns potentiate diagnosis, real time monitoring and treatment of diabetes.